A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2006
10/12/2006	US20060229342 TNF-a production inhibitors
10/12/2006	US20060229338 2,3'-bipyridines derivatives as selective cox-2 inhibitors
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229324 Quinazolin-4-one derivatives
10/12/2006	US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/12/2006	US20060229319 For treatment of allergies; antihistamines
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229273 High affinity oligonucleotide ligands to growth factors
10/12/2006	US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
10/12/2006	US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006	US20060229234 Peptide factor
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms
10/12/2006	DE102005016547A1 Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln Substituted 5,6,7,8-tetrahydro-imidazo (1,2-a) pyridin-2-ylamine compounds and their use for preparing medicaments
10/12/2006	DE102005015240A1 Oral use of ginger to reduce proliferation growth, particularly cancer proliferation in animal and human body
10/12/2006	CA2603826A1 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
10/12/2006	CA2603493A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments
10/12/2006	CA2603304A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
10/12/2006	CA2603214A1 Derivatives of[6,7-dihydro-5himidazo[1,2-alpha]imidazole-3-sulfonyl]-azetedine-carboxylic acids, esters and amides and use thereof as anti-inflammatory agents
10/12/2006	CA2603081A1 Device and methods for treating paranasal sinus conditions
10/12/2006	CA2603030A1 Benzyloxypropylamine derivative
10/11/2006	EP1710574A1 Method of screening compound safe to gastric mucosa
10/11/2006	EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710257A1 Hyaluronic acid derivative and drug containing the same
10/11/2006	EP1710242A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha levels
10/11/2006	EP1709976A1 Emt- inducing agents
10/11/2006	EP1709968A1 P2x receptor inhibitor
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709963A2 Use of amtolmetin guacyl for the production of a drug for counteracting blood platelet aggregation
10/11/2006	EP1709957A2 Sustained-release analgesic compounds
10/11/2006	EP1709175A2 Hif oligonucleotide decoy molecules
10/11/2006	EP1709056A1 Phosphoramidate derivatives
10/11/2006	EP1709046A1 P38 kinase inhibitors
10/11/2006	EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
10/11/2006	EP1708696A1 Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/11/2006	EP1708695A1 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
10/11/2006	EP1471896B1 Formulations for inhalation
10/11/2006	EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP0804479B1 Method of treating diabetes mellitus using kgf
10/11/2006	CN1845909A Quinoxaline derivatives as neutrophil elastase inhibitors and their use
10/11/2006	CN1845907A Guanidine derivatives
10/11/2006	CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use
10/11/2006	CN1845752A Use of soluble cd164 in inflammatory and/or autoimmune disorders
10/11/2006	CN1845743A Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
10/11/2006	CN1844121A Antipyretic analgesic and anti-arthritis nonsteroidal compound and its pharmaceutical compositions
10/11/2006	CN1844118A Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor
10/11/2006	CN1844114A Fukinanolide compounds and pharmaceutical application thereof
10/11/2006	CN1843501A Muscles and bones pain-stopping plaster and preparation method thereof
10/11/2006	CN1843493A Externally applied medicine for relieving pain and preparation method thereof
10/11/2006	CN1843443A Rheumatoid disease treating plaster
10/11/2006	CN1843441A Rheumatism-eliminating collaterals-dredging externally applied plaster
10/11/2006	CN1843439A Inflammation-resisting pain-stopping external use liquid and its preparation method
10/11/2006	CN1843421A Rheumatoid disease treating medicine
10/11/2006	CN1843405A Externally used traditional Chinese medicine formulation and medicinal bondage belt and bra for treating pain, and preparation method thereof
10/11/2006	CN1843395A Antibacterial and inflammatory-diminishing tincture containing bee glue
10/11/2006	CN1843351A Bilobalide B powder injection and its preparing method
10/11/2006	CN1843339A Use of resveratrol in treating rheumatoid arthritis and non-inflammatory disease
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity
10/11/2006	CN1279040C Tryasolyl tropane derivatives for therapy
10/11/2006	CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors
10/11/2006	CN1279014C Vitamin A analogue derivative with antiangiogenic, antitumoral and proapoptotic activities
10/11/2006	CN1278731C Compound bupleurum root medicinal preparation
10/11/2006	CN1278724C Externally used Chinese traditional medicine ointment
10/11/2006	CN1278711C External use Chinese medicinal lotion for treating gynecopathy inflammation
10/11/2006	CN1278710C Preventives or therapeutic agent of remedies for arthritis
10/11/2006	CN1278707C Chinese medicinal preparation for treating rheumatoid arthritis and its preparation method
10/11/2006	CN1278706C Medicine for treating arthralgia due to wind-cold dampness
10/11/2006	CN1278705C Orally disintegrating tablet of 'Tongxinluo' and its preparation
10/11/2006	CN1278685C Oral sustained releasing micropill of tuduranine and their preparation method
10/11/2006	CN1278683C Use of dipeptidyl peptidase IV inhibitor in preparing medicine for treating anxiety neurosis
10/11/2006	CN1278672C Pharmaceutical composition for intramuscular injection containing loxoprofen
10/10/2006	US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/10/2006	US7119122 Compounds for the inhibition of nitric oxide synthase
10/10/2006	US7119119 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/10/2006	US7119118 90-95% eicosapentaenoic acid (EPA) and < 5% of docosahexaenoic acid (DHA); treating psychiatric or central nervous disorders
10/10/2006	US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/10/2006	US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens
10/10/2006	US7119109 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/10/2006	US7119107 Pyridone derivatives
10/10/2006	US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts
10/10/2006	US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7118856 Enzyme catalyst; polypeptides; crystal structure
10/10/2006	US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA
10/10/2006	CA2352554C Substituted benzimidazoles and their use as parp inhibitors
10/10/2006	CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
10/10/2006	CA2290521C Medicinal aerosol products
10/10/2006	CA2280730C Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
10/10/2006	CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
10/10/2006	CA2255064C Potassium, sodium and tris oxaprozin salt pharmaceutical formulations

1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 1272